Direkt zum Inhalt
Merck

539136

Millipore

Protease Inhibitor Cocktail IV

liquid, for the inhibition of serine proteases, cysteine proteases, aspartic proteases and metalloproteases. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Synonym(e):

Protease inhibitor cocktail

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352200
NACRES:
NA.54

product name

Protease Inhibitor Cocktail Set IV, The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Form

liquid

Hersteller/Markenname

Calbiochem®

Lagerbedingungen

OK to freeze

Versandbedingung

wet ice

Lagertemp.

−20°C

Allgemeine Beschreibung

A cocktail of four protease inhibitors with broad specificity for the inhibition of aspartic-, cysteine-, metallo-, and serine-proteases. Recommended for fungal and yeast cell extracts. Each vial contains 100 mM AEBSF, HCl (Cat. No. 101500), 1.5 mM E-64 (Cat. No. 324890), 2 mM Pepstatin A (Cat. No. 516481), and 500 mM 1,10-Phenanthroline (Cat. No. 516705). Supplied with a data sheet. Note: 1 set = 5 x 1 ml.
The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Spezifität

Inhibits a broad spectrum of serine proteases, cysteine proteases, aspartic proteases, and metalloproteases.

Anwendung

Protease Inhibitor Cocktail Set IV, is a cocktail of four protease inhibitors with broad specificity for the aspartic, cysteine, metallo & serine-proteases. Recommended for fungal & yeast cells.

Biochem./physiol. Wirkung

Primary Target
aspartic-, cysteine-, metallo-, and serine-proteases
Product does not compete with ATP.

Warnhinweis

Toxicity: Toxic (F)

Physikalische Form

In 1 ml DMSO.

Rekonstituierung

Protease Inhibitor Cocktail Set IV can be used at a 1:100-1:1000 dilution for most applications.

Sonstige Hinweise

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

Rechtliche Hinweise

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Piktogramme

Exclamation markEnvironment

Signalwort

Warning

Gefahreneinstufungen

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 3

Flammpunkt (°F)

188.6 °F - Information refers to the main ingredient.

Flammpunkt (°C)

87 °C - Information refers to the main ingredient.


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Joseph V Geisberg et al.
Current protocols in molecular biology, 128(1), e101-e101 (2019-09-11)
Here we describe CLIP-READS, a technique that combines elements of crosslinking and immunoprecipitation (CLIP) and 3' region extraction and deep sequencing (READS), to provide a genome-wide map of mRNA 3' isoform binding by a given messenger ribonucleoprotein (mRNP). In CLIP-READS
Chao Luo et al.
Oncology letters, 21(2), 161-161 (2021-02-09)
The effects of microRNAs (miRNAs/miRs) on glioblastoma have attracted the attention of researchers in the last 7 years. However, the role of miR-640 and its targeted gene, Slit guidance ligand 1 (SLIT1), in the development of glioblastoma are not yet
Matthew M Seavey et al.
Current protocols in pharmacology, Chapter 5, Unit 5-Unit 5 (2011-09-22)
Systemic Lupus Erythematosus (SLE) is a debilitating and often fatal autoimmune disease that involves multiple organ systems. It can develop for years before being diagnosed. Current treatments for SLE usually involve the use of cytotoxic or immunosuppressive agents that can

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.